Chang Tsung-Cheng, Yu Duonan, Lee Yun-Sil, Wentzel Erik A, Arking Dan E, West Kristin M, Dang Chi V, Thomas-Tikhonenko Andrei, Mendell Joshua T
McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Nat Genet. 2008 Jan;40(1):43-50. doi: 10.1038/ng.2007.30. Epub 2007 Dec 9.
The c-Myc oncogenic transcription factor (Myc) is pathologically activated in many human malignancies. Myc is known to directly upregulate a pro-tumorigenic group of microRNAs (miRNAs) known as the miR-17-92 cluster. Through the analysis of human and mouse models of B cell lymphoma, we show here that Myc regulates a much broader set of miRNAs than previously anticipated. Unexpectedly, the predominant consequence of activation of Myc is widespread repression of miRNA expression. Chromatin immunoprecipitation reveals that much of this repression is likely to be a direct result of Myc binding to miRNA promoters. We further show that enforced expression of repressed miRNAs diminishes the tumorigenic potential of lymphoma cells. These results demonstrate that extensive reprogramming of the miRNA transcriptome by Myc contributes to tumorigenesis.
致癌转录因子c-Myc(Myc)在许多人类恶性肿瘤中发生病理激活。已知Myc可直接上调一组促肿瘤的微小RNA(miRNA),即miR-17-92簇。通过对B细胞淋巴瘤的人类和小鼠模型进行分析,我们在此表明,Myc调控的miRNA集合比先前预期的要广泛得多。出乎意料的是,Myc激活的主要后果是miRNA表达的广泛抑制。染色质免疫沉淀显示,这种抑制的大部分可能是Myc与miRNA启动子结合的直接结果。我们进一步表明,强制表达受抑制的miRNA可降低淋巴瘤细胞的致瘤潜力。这些结果表明,Myc对miRNA转录组的广泛重编程促进了肿瘤发生。